Scott Howard Dickerson

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Smithkline Beecham Corporation, Glaxo Wellcome Inc., Glaxosmithkline LLC. Active years: 1997-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Howard Dickerson. Retrieved from https://idiyas.com/inventor/scott-howard-dickerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 297(Granted Patents)

Location History:

Chapel Hill, NC (US) (1997 - 2006)
Durham, NC (US) (2004 - 2013)

Company Filing History:

9 out of 2,198

Smithkline Beecham Corporation

Years Active: 1997-2013

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8415345 - Benzene sulfonamide thiazole and oxazole compounds (2013-04-09),

2. 7812022 - 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors (2010-10-12),

3. 7582630 - Pyradazine compounds as GSK-3 inhibitors (2009-09-01),

4. 7279473 - Pyrazolopyridazine derivatives (2007-10-09),

5. 7189712 - 1,3-Oxazole compounds for the treatment of cancer (2007-03-13),

6. 7105529 - Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects (2006-09-12),

7. 7071217 - Substituted oxindole derivatives as tyrosine kinase inhibitors (2006-07-04),

8. 6762188 - Pharmaceutically active benzoquinazoline compounds (2004-07-13),

9. 6720332 - Oxindole derivatives (2004-04-13),

10. 6541503 - Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors (2003-04-01),

11. 6387919 - Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors (2002-05-14),

12. 6369086 - Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors (2002-04-09),

13. 6306865 - Pharmaceutically active benzoquinazoline compounds (2001-10-23),

14. 6268391 - Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases (2001-07-31),

15. 6172064 - Formamides as therapeutic agents (2001-01-09),

Title: Inventor Spotlight: Scott Howard Dickerson

Introduction

Scott Howard Dickerson is a notable inventor based in Durham, North Carolina, renowned for his contributions to the field of pharmaceuticals. With a portfolio that boasts 18 patents, Dickerson's work primarily focuses on innovative compounds that offer potential therapeutic benefits.

Latest Patents

Among his latest inventions are two significant patents:

1. **Benzene sulfonamide thiazole and oxazole compounds** - This invention provides thiazole sulfonamide and oxazole sulfonamide compounds, along with compositions containing these compounds. It also details processes for their preparation and methods for their use as pharmaceutical agents.

2. **2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors** - This invention offers 2-pyrimidinyl pyrazolopyridine compounds and their compositions, outlining processes for their preparation and applications as pharmaceutical agents.

Career Highlights

Scott Howard Dickerson has had a distinguished career, contributing to the pharmaceutical industry through his work at prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. His innovative mindset and expertise have significantly impacted the development of new therapeutic agents.

Collaborations

Throughout his career, Dickerson has collaborated with esteemed colleagues, including Philip Anthony Harris and Robert Neil Hunter, III. These partnerships have enabled the advancement of his research and the successful development of several patented inventions.

Conclusion

Scott Howard Dickerson stands out as a prolific inventor with a remarkable track record in the pharmaceutical field. His contributions through innovative patents continue to pave the way for advancements in therapeutic solutions, showcasing the importance of persistent research and collaboration in the industry.

Profile summary based on public USPTO records.